REFERENCES
1. World Health Organization Home Page. Available from https://www.who.int/. [accessed 15 September 2026].
2. Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The immune escape mechanisms of Mycobacterium tuberculosis. Int J Mol Sci. 2019;20:340.
3. Barry CE 3rd, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7:845-55.
4. Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol. 2015;13:620-30.
5. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
6. Khasabova IA, Khasabov SG, Simone DA. The role of cancer cell-released extracellular vesicles: have we become closer to cancer pain treatment? Extracell Vesicles Circ Nucleic Acids 2024;5:685-7.
7. Li Q, Ding Y, Shi Y, et al. 80 years of extracellular vesicles: from discovery to clinical translation. Extracell Vesicles Circ Nucleic Acids. 2026;7:165-233.
8. Zhou X, Xie F, Wang L, et al. The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol. 2020;17:323-34.
9. EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347-57.
10. Layre E. Trafficking of Mycobacterium tuberculosis envelope components and release within extracellular vesicles: host-pathogen interactions beyond the wall. Front Immunol. 2020;11:1230.
11. Prados-Rosales R, Baena A, Martinez LR, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest. 2011;121:1471-83.
12. Biadglegne F, König B, Rodloff AC, Dorhoi A, Sack U. Composition and clinical significance of exosomes in tuberculosis: a systematic literature review. J Clin Med. 2021;10:145.
13. Feltri V, Sanfilippo A, Tasso R, Ciferri MC. Extracellular vesicles as modulators of cancer metabolism and microenvironment. Extracell Vesicles Circ Nucleic Acids. 2026;7:51-72.
14. Hashemian SM, Pourhanifeh MH, Fadaei S, Velayati AA, Mirzaei H, Hamblin MR. Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis. Mol Ther Nucleic Acids. 2020;21:51-74.
15. Jurkoshek KS, Wang Y, Athman JJ, Barton MR, Wearsch PA. Interspecies communication between pathogens and immune cells via bacterial membrane vesicles. Front Cell Dev Biol. 2016;4:125.
16. Mukhtar F, Guarnieri A, Brancazio N, et al. The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers. Front Microbiol. 2024;15:1441781.
17. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood. 2007;110:3234-44.
18. Anand PK, Anand E, Bleck CK, Anes E, Griffiths G. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS One. 2010;5:e10136.
19. Chen Q, Chen J, Liu YN, Qi SH, Huang LY. Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion. Extracell Vesicles Circ Nucleic Acids. 2023;4:502-17.
20. Li H, Ding Y, Huang J, et al. Angiopep-2 modified exosomes load rifampicin with potential for treating central nervous system tuberculosis. Int J Nanomedicine. 2023;18:489-503.
21. Rath P, Huang C, Wang T, et al. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2013;110:E4790-7.
22. Lee J, Kim SH, Choi DS, et al. Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis. Proteomics. 2015;15:3331-7.
23. Hanafiah KM, Arifin N, Sanders PR, Othman N, Garcia ML, Anderson DA. Proteomic analysis of antigen 60 complex of M. bovis bacillus Calmette-Guérin reveals presence of extracellular vesicle proteins and predicted functional interactions. Vaccines. 2019;7:80.
24. Salgueiro-Toledo VC, Bertol J, Gutierrez C, et al. Maintenance of cell wall remodeling and vesicle production are connected in Mycobacterium tuberculosis. Elife. 2025;13:RP94982.
25. White DW, Elliott SR, Odean E, Bemis LT, Tischler AD. Mycobacterium tuberculosis Pst/SenX3-RegX3 regulates membrane vesicle production independently of ESX-5 activity. mBio. 2018;9:e00778-18.
26. Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol. 2012;10:525-37.
27. Prados-Rosales R, Weinrick BC, Piqué DG, Jacobs WR Jr, Casadevall A, Rodriguez GM. Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J Bacteriol. 2014;196:1250-6.
28. Rastogi S, Singh AK, Chandra G, et al. The diacylglycerol acyltransferase Rv3371 of Mycobacterium tuberculosis is required for growth arrest and involved in stress-induced cell wall alterations. Tuberculosis 2017;104:8-19.
29. Gupta S, Bhagavathula M, Sharma V, et al. Dynamin-like proteins mediate extracellular vesicle secretion in Mycobacterium tuberculosis. EMBO Rep. 2023;24:e55593.
30. Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
31. Liu S, Guan L, Peng C, et al. Mycobacterium tuberculosis suppresses host DNA repair to boost its intracellular survival. Cell Host Microbe. 2023;31:1820-36.e10.
32. Giri PK, Kruh NA, Dobos KM, Schorey JS. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages. Proteomics. 2010;10:3190-202.
33. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
34. Zhang Y, Lan M, Chen Y. Minimal Information for Studies of Extracellular Vesicles (MISEV): Ten-Year evolution (2014-2023). Pharmaceutics. 2024;16:1394.
35. Lai JJ, Chau ZL, Chen SY, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci. 2022;9:e2103222.
36. Sharma N, Sharma N, Biswas A, Gupta S, Behura A, Rodriguez GM. Iron-restricted Mycobacterium tuberculosis exports pathogenicity factors packed in extracellular vesicles. PLoS One. 2025;20:e0324919.
37. Davids CJ, Umashankar-Rao K, Kassaliete J, et al. The role of antibiotic-derived mycobacterial vesicles in tuberculosis pathogenesis. Sci Rep. 2024;14:28198.
38. Kruh-Garcia NA, Wolfe LM, Chaisson LH, et al. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One. 2014;9:e103811.
39. Diaz G, Wolfe LM, Kruh-Garcia NA, Dobos KM. Changes in the membrane-associated proteins of exosomes released from human macrophages after Mycobacterium tuberculosis infection. Sci Rep. 2016;6:37975.
40. Ramachandra L, Qu Y, Wang Y, et al. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun. 2010;78:5116-25.
41. Smith VL, Jackson L, Schorey JS. Ubiquitination as a mechanism to transport soluble mycobacterial and eukaryotic proteins to exosomes. J Immunol. 2015;195:2722-30.
42. Biadglegne F, Schmidt JR, Engel KM, et al. Mycobacterium tuberculosis affects protein and lipid content of circulating exosomes in infected patients depending on tuberculosis disease state. Biomedicines. 2022;10:783.
43. Vázquez-Flores L, Castañeda-Casimiro J, Vallejo-Castillo L, et al. Extracellular vesicles from Mycobacterium tuberculosis-infected neutrophils induce maturation of monocyte-derived dendritic cells and activation of antigen-specific Th1 cells. J Leukoc Biol. 2023;113:588-603.
44. Schaible UE, Winau F, Sieling PA, et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med. 2003;9:1039-46.
45. Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
46. Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27:172-88.
47. Singh A, Das K, Banerjee S, Sen P. Elucidation of the signalling pathways for enhanced exosome release from Mycobacterium-infected macrophages and subsequent induction of differentiation. Immunology. 2023;168:63-82.
48. Cheng Y, Schorey JS. Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing. EMBO Rep. 2019;20:e46613.
49. Singh PP, Li L, Schorey JS. Exosomal RNA from Mycobacterium tuberculosis-infected cells is functional in recipient macrophages. Traffic. 2015;16:555-71.
50. Russell AE, Sneider A, Witwer KW, et al. Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop. J Extracell Vesicles. 2019;8:1684862.
51. Arya R, Shakya H, Chaurasia R, Haque MA, Kim JJ. Exploring the role of extracellular vesicles in the pathogenesis of tuberculosis. Genes 2024;15:434.
52. Matsui T, Sakamaki Y, Hiragi S, Fukuda M. VAMP5 and distinct sets of cognate Q-SNAREs mediate exosome release. Cell Struct Funct. 2023;48:187-98.
53. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19:43-51.
54. Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364-72.
55. Ismail N, Wang Y, Dakhlallah D, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984-95.
57. Lee J, Kornfeld H. Interferon-γ regulates the death of M. tuberculosis-infected macrophages. J Cell Death. 2010;3:1-11.
58. Athman JJ, Sande OJ, Groft SG, et al. Mycobacterium tuberculosis membrane vesicles inhibit T cell activation. J Immunol. 2017;198:2028-37.
59. Chen HR, Huang HS, Zeng SY, et al. miR-146a-5p targets IRAK1/TRAF6 to promote bacillus Calmette-Guérin survival by exosome-mediated autocrine actions. Mol Immunol. 2025;185:105-15.
60. Cui X, Zhang F, Meng H, et al. Transport of miR-766-3p to A549 cells by plasma-derived exosomes and its effect on intracellular survival of Mycobacterium tuberculosis by regulating NRAMP1 expression in A549 cells. Microbiol Res. 2025;290:127943.
61. Giri PK, Schorey JS. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS One. 2008;3:e2461.
62. Yuan Q, Chen H, Yang Y, Fu Y, Yi Z. miR-18a promotes Mycobacterial survival in macrophages via inhibiting autophagy by down-regulation of ATM. J Cell Mol Med. 2020;24:2004-12.
63. Zhang D, Yi Z, Fu Y. Downregulation of miR-20b-5p facilitates Mycobacterium tuberculosis survival in RAW 264.7 macrophages via attenuating the cell apoptosis by Mcl-1 upregulation. J Cell Biochem. 2019;120:5889-96.
64. Hare NJ, Chan B, Chan E, Kaufman KL, Britton WJ, Saunders BM. Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics. 2015;15:3020-9.
65. Walters SB, Kieckbusch J, Nagalingam G, et al. Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration. J Immunol. 2013;190:669-77.
66. Tzelepis F, Verway M, Daoud J, et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J Clin Invest. 2015;125:752-68.
67. Dai J, Fang L, Fan Z, et al. Triphenylamine-substituted nile red derivatives with efficient reactive oxygen species generation for robust and broad-spectrum antimicrobial photodynamic therapy and abscess wound healing. Adv Funct Mater. 2025;35:2421072.
68. Ma F, Wang X, Qiu Z, et al. NK-derived exosome miR-1249-3p inhibits Mycobacterium tuberculosis survival in macrophages by targeting SKOR1. Cytokine. 2024;175:156481.
69. Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968-77.
70. Rao KU, Godaly G. Isolation and purification of mycobacterial extracellular vesicles (EVs). Methods Mol Biol. 2023;2674:55-60.
71. Wang W, Hou Y, Zhang J, Sun Z, Sun H. Improved isolation optimizes downstream application of extracellular vesicles derived from Mycobacterium tuberculosis. Microorganisms. 2024;12:2129.
72. Ryan JM, Shelton K, Dzieciatkowska M, Kruh-Garcia N, Dobos KM. Establishment of minimum protein standards for Mycobacterium tuberculosis-derived extracellular vesicles through comparison of EV enrichment methods. Mycobacteria. 2025;1:3.
73. Welsh JA, Goberdhan DCI, O'Driscoll L, et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
74. Verma A, Ghoshal A, Dwivedi VP, Bhaskar A. Tuberculosis: the success tale of less explored dormant Mycobacterium tuberculosis. Front Cell Infect Microbiol. 2022;12:1079569.
75. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 2010;8:296-307.
76. Mahon RN, Sande OJ, Rojas RE, Levine AD, Harding CV, Boom WH. Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation. Cell Immunol. 2012;275:98-105.
77. Sande OJ, Karim AF, Li Q, et al. Mannose-Capped lipoarabinomannan from Mycobacterium tuberculosis induces CD4+ T cell anergy via GRAIL. J Immunol. 2016;196:691-702.
78. Fratti RA, Chua J, Vergne I, Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A. 2003;100:5437-42.
79. Balaji KN, Goyal G, Narayana Y, Srinivas M, Chaturvedi R, Mohammad S. Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect. 2007;9:271-81.
80. Lv L, Li C, Zhang X, et al. RNA profiling analysis of the serum exosomes derived from patients with active and latent Mycobacterium tuberculosis infection. Front Microbiol. 2017;8:1051.
81. Singh PP, LeMaire C, Tan JC, Zeng E, Schorey JS. Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages. PLoS One. 2011;6:e18564.
82. Tang X, Hu F, Xia X, Zhang H, Zhou F, et al. [Mannose-capped lipoarabinomannan (ManLAM) binding TLR2 activates mast cells to release exosomes and induces M2 polarization of macrophages]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2021;37:481-6. (in Chinese).
83. Duarte TA, Noronha-Dutra AA, Nery JS, et al. Mycobacterium tuberculosis-induced neutrophil ectosomes decrease macrophage activation. Tuberculosis. 2012;92:218-25.
84. De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE 3rd. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A. 2000;97:1252-7.
85. Chiplunkar SS, Silva CA, Bermudez LE, Danelishvili L. Characterization of membrane vesicles released by Mycobacterium avium in response to environment mimicking the macrophage phagosome. Future Microbiol. 2019;14:293-313.
86. Rankine-Wilson LI, Shapira T, Sao Emani C, Av-Gay Y. From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis. Microbiology. 2021;167.
87. Phetkong C, Ariyachet C. MicroRNAs in liver fibrosis: unraveling intercellular crosstalk and the regulatory functions of microRNA-223. BIOI. 2025;6.
88. Trivedi J, Yasir M, Maurya RK, Tripathi AS. Aptamer-based theranostics in oncology: design strategies and limitations. BIOI. 2024;5.
89. Guio H, Aliaga-Tobar V, Galarza M, et al. Comparative profiling of circulating exosomal small RNAs derived from peruvian patients with tuberculosis and pulmonary adenocarcinoma. Front Cell Infect Microbiol. 2022;12:909837.
90. Wang Y, Chen C, Xu XD, et al. Levels of miR-125a-5p are altered in Mycobacterium avium-infected macrophages and associate with the triggering of an autophagic response. Microbes Infect. 2020;22:31-9.
91. Alipoor SD, Mortaz E, Tabarsi P, et al. Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages. J Transl Med. 2017;15:105.
92. Augenstreich J, Arbues A, Simeone R, et al. ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis. Cell Microbiol. 2017;19:e12726.
93. Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol. 2015;13:605-19.
94. Fulsundar S, Harms K, Flaten GE, Johnsen PJ, Chopade BA, Nielsen KM. Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. Appl Environ Microbiol. 2014;80:3469-83.
95. Wu M, Yang Q, Yang C, et al. Characteristics of plasma exosomes in drug-resistant tuberculosis patients. Tuberculosis. 2023;141:102359.
96. Yao X, Zhang L. Exploration of plasma exosomal miR-122-5p and its related targets KNG1 and C3 in the diagnosis of drug-resistant tuberculosis. Sci Rep. 2025;15:26620.
97. Smith VL, Cheng Y, Bryant BR, Schorey JS. Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection. Sci Rep. 2017;7:43578.
98. Yamaguchi T, Samukawa N, Matsumoto S, et al. BCG-derived acellular membrane vesicles elicit antimycobacterial immunity and innate immune memory. Front Immunol. 2025;16:1534615.
99. Singh S, Anshita D, Ravichandiran V. MCP-1: function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101:107598.
100. Singh PP, Smith VL, Karakousis PC, Schorey JS. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol. 2012;189:777-85.
101. Wang JJ, Chen C, Xie PF, Pan Y, Tan YH, Tang LJ. Proteomic analysis and immune properties of exosomes released by macrophages infected with Mycobacterium avium. Microbes Infect. 2014;16:283-91.
102. Liu M, Wang Z, Ren S, Zhao H. Exosomes derived from Mycobacterium tuberculosis-infected MSCs induce a pro-inflammatory response of macrophages. Aging. 2021;13:11595-609.
103. Guirado E, Schlesinger LS, Kaplan G. Macrophages in tuberculosis: friend or foe. Semin Immunopathol. 2013;35:563-83.
104. Goto Y, Ogawa Y, Tsumoto H, et al. Contribution of the exosome-associated form of secreted endoplasmic reticulum aminopeptidase 1 to exosome-mediated macrophage activation. Biochim Biophys Acta Mol Cell Res. 2018;1865:874-88.
105. Xu W, Wu Y, Yang M, et al. miR-107-enriched exosomes promote ROS/wnt/autophagy, inhibit intracellular mycobacterial growth and attenuate lung infection. Front Immunol. 2025;16:1567167.
106. Dai Y, Wang X, Du W, et al. NK cell-derived exosomes inhibit survival of Mycobacterium tuberculosis by promoting apoptosis in mice. Cytokine. 2025;185:156820.
107. Alvarez-Jiménez VD, Leyva-Paredes K, García-Martínez M, et al. Extracellular vesicles released from Mycobacterium tuberculosis-infected neutrophils promote macrophage autophagy and decrease intracellular mycobacterial survival. Front Immunol. 2018;9:272.
108. Kim H, Shin SJ. Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion. Front Cell Infect Microbiol. 2022;12:891878.
109. Prados-Rosales R, Carreño LJ, Batista-Gonzalez A, et al. Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis. mBio. 2014;5:e01921-14.
110. Benet S, Gálvez C, Drobniewski F, et al. Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles. J Extracell Vesicles. 2021;10:e12046.
111. Segura E, Nicco C, Lombard B, et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood. 2005;106:216-23.
112. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell. 2009;136:37-49.
113. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science. 2010;327:466-9.
114. Li L, Cheng Y, Emrich S, Schorey J. Activation of endothelial cells by extracellular vesicles derived from Mycobacterium tuberculosis infected macrophages or mice. PLoS One. 2018;13:e0198337.
115. Yan K, Xu G, Li Z. MicroRNA-20b carried by mesenchymal stem cell-derived extracellular vesicles protects alveolar epithelial type II cells from Mycobacterium tuberculosis infection in vitro. Infect Genet Evol. 2022;101:105292.
116. Tyagi P, Pal VK, Agrawal R, Singh S, Srinivasan S, Singh A. Mycobacterium tuberculosis reactivates HIV-1 via exosome-mediated resetting of cellular redox potential and bioenergetics. mBio. 2020;11:e03293-19.
117. Zhang M, Xie Y, Li S, et al. Proteomics analysis of exosomes from patients with active tuberculosis reveals infection profiles and potential biomarkers. Front Microbiol. 2021;12:800807.
118. Jin Y, Liu Y, Yu W, et al. Exosomal microRNAs associated with tuberculosis among people living with human immunodeficiency virus. J Clin Tuberc Other Mycobact Dis. 2024;36:100453.
119. Cheng Y, Schorey JS. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection. Eur J Immunol. 2013;43:3279-90.
120. Sharma R, Rajput VS, Jamal S, Grover A, Grover S. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci Rep. 2021;11:13836.
121. Cheng Y, Schorey JS. Targeting soluble proteins to exosomes using a ubiquitin tag. Biotechnol Bioeng. 2016;113:1315-24.
122. Ji L, Fu Y, Xiong S. Chimeric antigen carried by extracellular vesicles induces stronger protective immunity against Mycobacterium tuberculosis infection. Immunobiology. 2024;229:152834.
123. George E, Goswami A, Lodhiya T, et al. Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles. Biomater Adv. 2022;139:213003.
124. Montalvo-Quirós S, Vallet-Regí M, Palacios A, et al. Mesoporous silica nanoparticles as a potential platform for vaccine development against tuberculosis. Pharmaceutics. 2020;12:1218.
125. Kasule GW, Hermans S, Semugenze D, et al. ; Stool4TB Global Partnership. Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis. Eur J Med Res. 2024;29:502.
126. Wang W, Wang J, Hu Z, et al. Advancing aggregation-induced emission-derived biomaterials in viral, tuberculosis, and fungal infectious diseases. Aggregate. 2025;6:e715.
127. Wang W, Liu Z, Li M, et al. AIEgen-based proactive early warning system and precise treatment strategy for monkeypox prevention and control. Adv Sci. 2026;13:e15865.
128. Hu Z, Wang W, Lin Y, et al. Extracellular vesicle-inspired therapeutic strategies for the COVID-19. Adv Healthc Mater. 2024;13:e2402103.
129. Alipoor SD, Tabarsi P, Varahram M, et al. Serum exosomal miRNAs are associated with active pulmonary tuberculosis. Dis Markers. 2019;2019:1907426.
130. Kaushik AC, Wu Q, Lin L, et al. Exosomal ncRNAs profiling of mycobacterial infection identified miRNA-185-5p as a novel biomarker for tuberculosis. Brief Bioinform. 2021;22:bbab210.
131. Hu X, Liao S, Bai H, et al. Integrating exosomal microRNAs and electronic health data improved tuberculosis diagnosis. EBioMedicine. 2019;40:564-73.
132. Fang Y, Zhao J, Wang X, et al. Identification of differentially expressed lncRNAs as potential plasma biomarkers for active tuberculosis. Tuberculosis. 2021;128:102065.
133. Lu G, Jiang X, Wu A, et al. Two small extracellular vesicle sRNAs derived from Mycobacterium tuberculosis serve as diagnostic biomarkers for active pulmonary tuberculosis. Front Microbiol. 2021;12:642559.
134. Gu W, Huang Z, Fan Y, et al. Peripheral blood microbiome signature and Mycobacterium tuberculosis-derived rsRNA as diagnostic biomarkers for tuberculosis in human. J Transl Med. 2025;23:204.
135. Lawn SD, Kerkhoff AD, Burton R, et al. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort. BMC Med. 2017;15:67.
136. Liu C, Zhao Z, Fan J, et al. Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. Proc Natl Acad Sci U S A. 2017;114:3969-74.
137. Wang L, Zheng X, Ma J, Gu J, Sha W. Comparative proteomic analysis of exosomes derived from patients infected with non-tuberculous Mycobacterium and Mycobacterium tuberculosis. Microorganisms. 2023;11:2334.
138. Jiang Y, Yan L, Zhou B, et al. Identifying plasma exosome antigens as a potential diagnostic biomarker for tuberculosis disease. BMC Infect Dis. 2025;25:65.
139. Huang C, Pan L, Shen X, et al. Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis. Eur J Clin Microbiol Infect Dis. 2021;40:2427-30.
140. Dahiya B, Khan A, Mor P, et al. Detection of Mycobacterium tuberculosis lipoarabinomannan and CFP-10 (Rv3874) from urinary extracellular vesicles of tuberculosis patients by immuno-PCR. Pathog Dis. 2019;77:ftz049.
141. Lyu L, Zhang X, Li C, et al. Small RNA profiles of serum exosomes derived from individuals with latent and active tuberculosis. Front Microbiol. 2019;10:1174.
142. Mehaffy C, Kruh-Garcia NA, Graham B, et al. Identification of Mycobacterium tuberculosis peptides in serum extracellular vesicles from persons with latent tuberculosis infection. J Clin Microbiol. 2020;58:e00393-20.
143. Zheng W, LaCourse SM, Song B, et al. Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples. Nat Biomed Eng. 2022;6:979-91.
144. Lyu L, Jia H, Liu Q, et al. Individualized lipid profile in urine-derived extracellular vesicles from clinical patients with Mycobacterium tuberculosis infections. Front Microbiol. 2024;15:1409552.
145. Kushwaha S, Yadav R, Kumar R, Kumar S, Chauhan DS, Vir Singh A. Expression profiling & functional characterization of candidate miRNAs in serum exosomes among Indians with & without HIV-tuberculosis coinfection. Indian J Med Res. 2024;159:653-62.
146. Sun Z, Pang X, Wang X, Zeng H. Differential expression analysis of miRNAs in macrophage-derived exosomes in the tuberculosis-infected bone microenvironment. Front Microbiol. 2023;14:1236012.
148. Zhang X, Bao L, Yu G, Wang H. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis. Front Surg. 2022;9:1050242.
149. Wang Y, Xu YM, Zou YQ, et al. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions. Medicine. 2017;96:e8361.
150. Jindal N, Sharma P, Punia S, et al. Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept study. Tuberculosis. 2025;150:102578.
151. Luo P, Mao K, Xu J, et al. Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy. J Extracell Vesicles. 2020;9:1790158.
152. Goletti D, Lee MR, Wang JY, Walter N, Ottenhoff THM. Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease. Respirology. 2018;23:455-66.
153. Carranza C, Herrera MT, Guzmán-Beltrán S, et al. A dual marker for monitoring MDR-TB treatment: host-derived miRNAs and M. tuberculosis-derived RNA sequences in serum. Front Immunol. 2021;12:760468.
154. Zhang Y, Zhang L, Shi L, et al. Plasma exosomal miR-122-5p_R-1, miR-23b-3p_R + 1, and miR-15a-5p_R-1 are associated with multidrug-resistant tuberculosis. BMC Infect Dis. 2025;25:1063.
155. Du Y, Xin H, Cao X, et al. Association between plasma exosomes S100A9/C4BPA and latent tuberculosis infection treatment: proteomic analysis based on a randomized controlled study. Front Microbiol. 2022;13:934716.
156. Palacios A, Sampedro L, Sevilla IA, et al. Mycobacterium tuberculosis extracellular vesicle-associated lipoprotein LpqH as a potential biomarker to distinguish paratuberculosis infection or vaccination from tuberculosis infection. BMC Vet Res. 2019;15:188.
157. García-Barberán V, Gómez Del Pulgar ME, Guamán HM, Benito-Martin A. The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer. Extracell Vesicles Circ Nucleic Acids. 2025;6:128-40.
158. Wang W, Guo H, Lin S, et al. Biosafety materials for tuberculosis treatment. Biosaf Health. 2022;4:258-68.
159. Li B, Wang W, Zhao L, et al. Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles. Nat Nanotechnol. 2024;19:834-45.
160. Hagedorn L, Jürgens DC, Merkel OM, Winkeljann B. Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design. Extracell Vesicles Circ Nucleic Acids. 2024;5:344-57.
161. de Rezende CP, de Lima Alves D, de Almeida Chuffa LG, Pires de Campos Zuccari DA. Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives. Extracell Vesicles Circ Nucleic Acids. 2025;6:54-71.
162. Amreddy N, Srivastava A, Riedinger N, et al. Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy. Extracell Vesicles Circ Nucleic Acids. 2025;6:1054-78.
163. Wang W, Li B, Wu Y, et al. Macrophage-derived biomimetic nanoparticles for light-driven theranostics toward Mpox. Matter. 2024;7:1187-206.
164. Zhang H, Wang S, Sun M, et al. Exosomes as smart drug delivery vehicles for cancer immunotherapy. Front Immunol. 2022;13:1093607.
165. Pi J, Ma Y, Wang W, et al. Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis. Int Immunopharmacol. 2025;167:115696.
166. Fang L, Wang W, Dai J, et al. Engineered nile red derivatives-mediated efficient phototherapy against drug-resistant bacteria and monkeypox virus. Aggregate. 2025;6:e70130.
167. Wang W, Mo W, Xiao X, et al. Antibiotic-loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria. Asian J Pharm Sci. 2024;19:100926.
168. Li D, Li S, He S, He H, Yuan G, et al. Restoring tendon microenvironment in tendinopathy: macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes. Bioact Mater. 2025;47:152-69.
169. Fan MH, Pi JK, Zou CY, et al. Hydrogel-exosome system in tissue engineering: a promising therapeutic strategy. Bioact Mater. 2024;38:1-30.
